Preview

Pacific Medical Journal

Advanced search

FEATURES OF AGMATINE ANALGETIC EFFECT IN THE MODEL OF TONIC INFLAMMATORY PAIN

Abstract

Among the potential bipolar analgesics the imidazoline receptor stimulants are currently under consideration, their effect probably simulates the one of certain endogenous agonist, the most likely candidate for the role of which is a polyamine agmatine. Methods. In the experiment on nonlinear male rats during intraperitoneal introduction the researchers examined the agmatine sulphate effect on the severity of pain sensitivity and nociceptive threshold parameters on the model of tonic inflammatory pain. After taking the animals out of the experience the researchers using the method of high-performance liquid chromatography determined the agmatine content in different parts of the brain and in the cerebrospinal fluid. Results. Introduction of agmatine sulphate in the dose of 50, 100 and 200 mg/kg has reduced the severity of pain, mainly, at the tonic pain stage. Introduction of agmatine to the intact animals did not change the initial threshold of the temperature pain sensitivity but increased activity of «analgesia caused by pain.» After injection the drug accumulates in the spinal cord, brain and cerebrospinal fluid. Conclusions. Agmatine anti-algetic effect, probably, is due to its effect on the activity of different signaling mechanisms of the central nervous system, particularly the system of nitric oxide synthesis. The presence of the drug after intraperitoneal introduction in different parts of the brain indicates its ability to break the blood-brain barrier. This fact, along with the results of testing the agmatine biological activity allows to consider agmatineergic system of the brain as a potential target of analgesics.

About the Authors

I. V. Dyuyzen
Pacific State Medical University; Institute of Marine Biology named after A.V. Zhirmunskiy FEB RAS
Russian Federation


T. V. Balashova
Pacific State Medical University
Russian Federation


N. E. Lamash
Institute of Marine Biology named after A.V. Zhirmunskiy FEB RAS
Russian Federation


L. A. Mnatsakanyan
Pacific State Medical University
Russian Federation


A. A. Sosin
Pacific State Medical University
Russian Federation


A. O. Bykov
Pacific State Medical University
Russian Federation


V. B. Shumatov
Pacific State Medical University
Russian Federation


References

1. Волчков В.А., Игнатов Ю.Д., Страшнов В.И. Болевые синдромы в анестезиологии и реаниматологии. М.: МЕДпресс-информ, 2006. 320 с.

2. Дюйзен И.В., Балашова Т.В., Ламаш Н.Е. [и др.] Нейротрансмиттерная роль агматина, его взаимодействие с классическими нейромедиаторами и участие в механизмах развития боли // Тихоокеанский мед. журнал. 2013. № 4. С. 26-32.

3. Дюйзен И.В., Ламаш Н.Е. Взаимодействие NO- и норадренергической систем головного мозга в механизмах боли и опиатной аналгезии // Вестник ДВО РАН. 2006. № 2. С. 70-76.

4. Дюйзен И.В., Ламаш Н.Е. Влияние NO-модулирующих препаратов на развитие острой болевой реакции у крыс // Бюл. эксперимент. биол. и мед. 2008. № 8. С. 179-182.

5. Осипова Н.А., Петрова В.В. Боль в хирургии. Средства и способы защиты. М.: МИА, 2013. 464 с.

6. Aggarwal S., Shavalian B., Kim E., Rawls S.M. Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception // Pharmacol., Biochem. Behavior. 2009. Vol. 93. P. 426-432.

7. Fairbanks C.A., Schreiber K.L., Brewer K.L. [et al.] Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury// Proc. Natl. Acad. Sci. USA. 2000. Vol. 97, No. 19. P. 10584-10589.

8. Halaris A., Piletz J. Agmatine: metabolic pathway and spectrum of activity in brain // CNS Drugs. 2007. Vol. 21, No. 11. P. 885-900.

9. Horvath G., Kekesi G., Dobos I. et al. Effect of intrathecalagmatine on inflammation-induced thermal hyperalgesia in rats // Eur. J. Phramacol. 1999. Vol. 368, No. 2-3. P. 197-204.

10. Janicki P.K., Parris W. Animal models for pain research // Current Pain and Headache Reports. 1997. Vol. 1. P. 271-277

11. Kolesnikov Y.A., Jain S., Wilson R. [et al.] Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance // J. Pharmacol. Exp. Ther. 1996. Vol. 279, No. 2. P. 502-506.

12. Nakanishi O., Ishikawa T., Harano N. [et al.] The analgetk effect of agmatine in formalin-induced pain is enhanced by an NMDA-receptor antagonists // European Journal of Pain. 2009. Vol. 13. P. S55-S285.

13. Masuko T., Kusama-Eguchi K., Sakata K. [et al.] Polyamine transport, accumulation, and release in brain // Journal of Neurochemistry. 2003. Vol. 84. P. 610-617.

14. Millan M.J. The induction of pain: an integrative review // Prog. Neurobiol. 1999. Vol. 7. P. 151-164.

15. Su R.-B., Li J., Qin B.-Y. A biphasic opioid function modulator: agmatine // Acta Pharmacol. Sin. 2003. Vol. 24, No. 7. P. 631-636.


Review

For citations:


Dyuyzen I.V., Balashova T.V., Lamash N.E., Mnatsakanyan L.A., Sosin A.A., Bykov A.O., Shumatov V.B. FEATURES OF AGMATINE ANALGETIC EFFECT IN THE MODEL OF TONIC INFLAMMATORY PAIN. Pacific Medical Journal. 2014;(2):43-47. (In Russ.)

Views: 361


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1609-1175 (Print)